KAYLA TEIVES
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CLARKSVILLE, IN NPI 1124565239
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family IN Acerta Pharma LLC All categories
General Payments — all program years on this page
$8,369.35
- Category: General Payments
- Program years: PY2021–2024
- Record count: 489
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,088.32 across 42 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,088.32 | 42 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $311.81 | 4 |
| ITI, Inc. | $198.77 | 9 |
| ABBVIE INC. | $73.53 | 3 |
| Teva Pharmaceuticals USA, Inc. | $72.90 | 4 |
| Gilead Sciences, Inc. | $62.82 | 3 |
| Exact Sciences Corporation | $49.04 | 2 |
| Lundbeck LLC | $48.28 | 3 |
| Vanda Pharmaceuticals Inc. | $47.94 | 2 |
| Neurocrine BioSciences, Inc. | $35.79 | 2 |
| Alkermes, Inc. | $34.70 | 2 |
| Otsuka America Pharmaceutical, Inc. | $23.94 | 1 |
| Merck Sharp & Dohme Corporation | $22.31 | 1 |
| Tandem Diabetes Care, Inc. | $22.17 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.79 | 1 |
| GlaxoSmithKline, LLC. | $17.42 | 1 |
| Novo Nordisk AS | $16.78 | 1 |
| Indivior Inc. | $16.43 | 1 |
| Almatica Pharma Inc. | $13.90 | 1 |
By program year
Records — PY2024 (42)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.